Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2247 ARTÍCULOS , VIENDO DEL 1516 AL 1530

Brexpiprazole for the treatment of agitation associated with dementia due to Alzheimer's disease: A 12-week, active-treatment, extension trial

Behl S, Slomkowski M, Chen D, Chang D, Hefting N, Lee D, Shah A, Estilo A, Kalu U, Hobart M.

J Alzheimers Dis. 2024 Nov;102(2):520-529. doi: 10.3233/JAD-240491. Epub 2024 Nov 13.

Cognitive reserve against Alzheimer's pathology is linked to brain activity during memory formation

Vockert N, Machts J, Kleineidam L, Nemali A, Incesoy EI, Bernal J, Schütze H, Yakupov R, Peters O, Gref D, Schneider LS, Preis L, Priller J, Spruth EJ, Altenstein S, Schneider A, Fliessbach K, Wiltfang J, Rostamzadeh A, Glanz W, Teipel S, Kilimann I, Goerss D, Laske C, Munk MH, Spottke A, Roy N, Heneka MT, Brosseron F, Wagner M, Wolfsgruber S, Dobisch L, Dechent P, Hetzer S, Scheffler K, Zeidman P, Stern Y, Schott BH, Jessen F, Düzel E, Maass A, Ziegler G; DELCODE study group.

Nat Commun. 2024 Nov 13;15(1):9815. doi: 10.1038/s41467-024-53360-9.

The Italian guideline on diagnosis and treatment of dementia and mild cognitive impairment

Fabrizi E, Ancidoni A, Locuratolo N, Piscopo P, Della Gatta F, Salemme S, Pani SM, Marconi D, Vignatelli L, Sagliocca L, Caffarra P, Secreto P, Guaita A, Stracciari A, Vanacore N, Lacorte E; Guideline Working Group.

Age Ageing. 2024 Nov 1;53(11):afae250. doi: 10.1093/ageing/afae250.

A Review of Dextromethorphan-Quinidine for the Treatment of Agitation in Dementia

Khan AN, Murphy KS, Tampi RR.

Prim Care Companion CNS Disord. 2024 Nov 14;26(6):24nr03737. doi: 10.4088/PCC.24nr03737.

[Behavioral variant of frontotemporal dementia with stereotypic speech: a case report]

Ueda Y, Matsuo K, Matsuda K, Momosaki R, Shindo A, Tomimoto H.

Rinsho Shinkeigaku. 2024 Dec 21;64(12):878-883. doi: 10.5692/clinicalneurol.cn-001969. Epub 2024 Nov 16.

Initial Experience with Lecanemab and Lessons Learned in 71 Patients in a Regional Medical Center

Shields LBE, Hust H, Cooley SD, Cooper GE, Hart RN, Dennis BC, Freeman SW, Cain JF, Shang WY, Wasz KM, Orr AT, Shields CB, Barve SS, Pugh KG.

J Prev Alzheimers Dis. 2024;11(6):1549-1562. doi: 10.14283/jpad.2024.159.

Development and Concurrent Validity of the Short-Form CogDrisk Dementia Risk Assessment Tool

Anstey KJ, Huque MH, Kootar S, Eramudugolla R, Li M.

J Prev Alzheimers Dis. 2024;11(6):1751-1758. doi: 10.14283/jpad.2024.108.

Primary Progressive Aphasia in Italian and English: A Cross-Linguistic Cohort Study

Mazzeo S, Hardy CJD, Jiang J, Morinelli C, Moschini V, Brooks E, Johnson JCS, Chokesuwattanaskul A, Giacomucci G, Volkmer A, Rohrer JD, Ingannato A, Bagnoli S, Padiglioni S, Nacmias B, Sorbi S, Bessi V, Warren JD.

Neurology. 2024 Dec 24;103(12):e210058. doi: 10.1212/WNL.0000000000210058. Epub 2024 Nov 21.

The Role of Epileptic Activity in Alzheimer's Disease

Chen TS, Lai MC, Hong WP, Huang CW.

Am J Alzheimers Dis Other Demen. 2024 Jan-Dec;39:15333175241303569. doi: 10.1177/15333175241303569.

Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study

Schworer EK, Zammit MD, Wang J, Handen BL, Betthauser T, Laymon CM, Tudorascu DL, Cohen AD, Zaman SH, Ances BM, Mapstone M, Head E, Christian BT, Hartley SL; Alzheimer's Biomarker Consortium–Down Syndrome (ABC–DS).

Lancet Neurol. 2024 Dec;23(12):1214-1224. doi: 10.1016/S1474-4422(24)00426-5.

Deprescribing anticholinergics to preserve brain health: reducing the risk of dementia through deprescribing (R2D2): study protocol for a randomized clinical trial

Campbell NL, Holden RJ, Gao S, Unverzagt FW, Lane KA, Carter A, Harrington AB, Manoharan S, Manoharan N, Rosenthal DL, Pitts C, Pelkey K, Papineau E, Lauck DM, Keshk N, Alamer K, Khalil H, Boustani MA.

Trials. 2024 Nov 22;25(1):788. doi: 10.1186/s13063-024-08618-4.

Validation of the Quick Mild Cognitive Impairment Screen in an American Sample of Patients With Mild Cognitive Impairment and Mild Dementia

Fernandez DA, Schmitz S, Foil H, Brouillette R, Keller JN, Hilsabeck RC.

Int J Geriatr Psychiatry. 2024 Nov;39(11):e70026. doi: 10.1002/gps.70026.

Effect of Social Isolation Due to the COVID-19 Pandemic on Cognitive Dysfunction of Patients With Alzheimer Disease: Subanalysis of Double-blinded Noninferiority Study of Donepezil Patches and Donepezil Tablets

Nakamura Y, Omori T, Nishiyama K, Ishikawa I, Aoki H, Nagakura N.

Alzheimer Dis Assoc Disord. 2024 Oct-Dec 01;38(4):351-357. doi: 10.1097/WAD.0000000000000648. Epub 2024 Nov 13.

Navigating Alzheimer's Disease Mouse Models: Age-Related Pathology and Cognitive Deficits

De Plano LM, Saitta A, Oddo S, Caccamo A.

Biomolecules. 2024 Nov 5;14(11):1405. doi: 10.3390/biom14111405.

Infectious Disease as a Modifiable Risk Factor for Dementia: A Narrative Review

Farrer TJ, Moore JD, Chase M, Gale SD, Hedges DW.

Pathogens. 2024 Nov 7;13(11):974. doi: 10.3390/pathogens13110974.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias